Result: After a median antepartum zidovudine duration of 10.4 weeks in both groups and an additional 4 weeks postpartum zidovudine-plus-didanosine in PHPT-4, new
NRTI resistance mutations were detected by consensus sequencing in five PHPT-4 subjects (2.3%; four
K70R and one
D67N+
K70R) and two PHPT-2 controls (0.9%; one
D67N, one
K70R) (Table 4).